Advertisement
UK markets close in 4 hours 37 minutes
  • FTSE 100

    8,066.88
    +43.01 (+0.54%)
     
  • FTSE 250

    19,729.22
    +129.83 (+0.66%)
     
  • AIM

    753.56
    +4.38 (+0.58%)
     
  • GBP/EUR

    1.1588
    -0.0000 (-0.00%)
     
  • GBP/USD

    1.2347
    -0.0004 (-0.03%)
     
  • Bitcoin GBP

    53,658.75
    +154.32 (+0.29%)
     
  • CMC Crypto 200

    1,424.30
    +9.54 (+0.67%)
     
  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     
  • DOW

    38,239.98
    +253.58 (+0.67%)
     
  • CRUDE OIL

    81.69
    -0.21 (-0.26%)
     
  • GOLD FUTURES

    2,316.80
    -29.60 (-1.26%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     
  • DAX

    18,044.80
    +184.00 (+1.03%)
     
  • CAC 40

    8,089.28
    +48.92 (+0.61%)
     

India's Ranbaxy in ingredient supplier talks for generic Nexium - source

MUMBAI, March 11 (Reuters) - Indian drugmaker Ranbaxy Laboratories Ltd is in talks with at least two companies on sourcing ingredients for a generic version of AstraZeneca Plc (NYSE: AZN - news) 's heartburn pill Nexium, a person with direct knowledge of the matter said, after a U.S. ban on shipments from a plant in India.

The source declined to give details and refused to be named due to the sensitivity of the issue.

A Ranbaxy spokesman said the company has no comment for now (SES: E2:OJ4.SI - news) .